IRCT2017042433619N1已完成3 期
Assessment of Treatment with Carvedilol in Preventing Heart failure in breast cancer patients under treatment with herceptin or anthracyclines.
Vice chancellor for research of Baqiyatallah University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- Female
入选标准
- •breast cancer patients under treatment with herceptin or antracyclines.
- •Exclusion criteria: EF less than50%; Significant Valvular Heart Disease; GFR<30ml/h/m2; Hepatic Failure; Contraindications for beta blockers; Symptoms of Heart Failure.
排除标准
- 未提供
研究者
相似试验
已完成
2 期
Study the preventive effect of Carvedilol therapy against Adriamycin-induced acute cardiotoxicity in breast cancer patients by measurement of myocardial deformation indexCongestive heart failureCondition 1: breast cancer. Condition 2: heart failure.Breast, unspecifiedIRCT2013093012924N1Vice chancellor for research, Mashhad University of Medical Sciences70
招募中
3 期
Effect of Carvedilol on Reducing Transtosomab Cardiac ComplicationsIRCT20190628044046N1Tehran University of Medical Sciences60
招募中
3 期
Evaluation of the effect of carvedilol in patients with gastrointestinal cancerGastrointestinal cancers (Esophageal cancer, Gastric cancer, Pancreatic cancer, Colon cancer).Malignant neoplasm of stomachIRCT20200907048646N1Ardabil University of Medical Sciences60
尚未招募
不适用
S1501 Prospective Evaluation of Carvedilol in Prevention of Cardiac Toxicity in Patients with Metastatic HER-2+ Breast Cancer, Phase III”NeoplasmsKCT0004843ational Cancer Center20
已完成
3 期
Evaluation of Early Disease in Familial Dilated CardiomyopathyFamilial dilated cardiomyopathyCardiovascular - Other cardiovascular diseasesACTRN12605000204640St Vincent's Hospital, Darlinghurst64